IBDEI0WK ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16123,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16123,1,2,0)
 ;;=2^J0129
 ;;^UTILITY(U,$J,358.3,16123,1,3,0)
 ;;=3^ABATACEPT INJ 10MG
 ;;^UTILITY(U,$J,358.3,16124,0)
 ;;=J1460^^104^998^17^^^^1
 ;;^UTILITY(U,$J,358.3,16124,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16124,1,2,0)
 ;;=2^J1460
 ;;^UTILITY(U,$J,358.3,16124,1,3,0)
 ;;=3^GAMMA GLOBULIN INJ 1CC
 ;;^UTILITY(U,$J,358.3,16125,0)
 ;;=J1560^^104^998^18^^^^1
 ;;^UTILITY(U,$J,358.3,16125,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16125,1,2,0)
 ;;=2^J1560
 ;;^UTILITY(U,$J,358.3,16125,1,3,0)
 ;;=3^GAMMA GLOBULIN INJ > 10CC
 ;;^UTILITY(U,$J,358.3,16126,0)
 ;;=J1561^^104^998^19^^^^1
 ;;^UTILITY(U,$J,358.3,16126,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16126,1,2,0)
 ;;=2^J1561
 ;;^UTILITY(U,$J,358.3,16126,1,3,0)
 ;;=3^GAMUNEX 500MG
 ;;^UTILITY(U,$J,358.3,16127,0)
 ;;=J2353^^104^998^41^^^^1
 ;;^UTILITY(U,$J,358.3,16127,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16127,1,2,0)
 ;;=2^J2353
 ;;^UTILITY(U,$J,358.3,16127,1,3,0)
 ;;=3^OCTREOTIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,16128,0)
 ;;=J1930^^104^998^27^^^^1
 ;;^UTILITY(U,$J,358.3,16128,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16128,1,2,0)
 ;;=2^J1930
 ;;^UTILITY(U,$J,358.3,16128,1,3,0)
 ;;=3^LANREOTIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,16129,0)
 ;;=J0561^^104^998^43^^^^1
 ;;^UTILITY(U,$J,358.3,16129,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16129,1,2,0)
 ;;=2^J0561
 ;;^UTILITY(U,$J,358.3,16129,1,3,0)
 ;;=3^PEN G BENZATHINE 100,000 UNITS
 ;;^UTILITY(U,$J,358.3,16130,0)
 ;;=J0558^^104^998^44^^^^1
 ;;^UTILITY(U,$J,358.3,16130,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16130,1,2,0)
 ;;=2^J0558
 ;;^UTILITY(U,$J,358.3,16130,1,3,0)
 ;;=3^PEN G BENZATHINE/PROCAINE INJ 100,000 UNITS
 ;;^UTILITY(U,$J,358.3,16131,0)
 ;;=J2540^^104^998^45^^^^1
 ;;^UTILITY(U,$J,358.3,16131,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16131,1,2,0)
 ;;=2^J2540
 ;;^UTILITY(U,$J,358.3,16131,1,3,0)
 ;;=3^PEN G POTASSIUM INJ 600,000 UNITS
 ;;^UTILITY(U,$J,358.3,16132,0)
 ;;=J2510^^104^998^46^^^^1
 ;;^UTILITY(U,$J,358.3,16132,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16132,1,2,0)
 ;;=2^J2510
 ;;^UTILITY(U,$J,358.3,16132,1,3,0)
 ;;=3^PEN G PROCAINE INJ UP TO 600,000 UNITS
 ;;^UTILITY(U,$J,358.3,16133,0)
 ;;=J3370^^104^998^56^^^^1
 ;;^UTILITY(U,$J,358.3,16133,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16133,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,16133,1,3,0)
 ;;=3^VANCOMYCIN HCI INJ 500MG
 ;;^UTILITY(U,$J,358.3,16134,0)
 ;;=J0696^^104^998^7^^^^1
 ;;^UTILITY(U,$J,358.3,16134,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16134,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,16134,1,3,0)
 ;;=3^CEFTRIAXONE SODIUM INJ 250MG
 ;;^UTILITY(U,$J,358.3,16135,0)
 ;;=J0692^^104^998^6^^^^1
 ;;^UTILITY(U,$J,358.3,16135,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16135,1,2,0)
 ;;=2^J0692
 ;;^UTILITY(U,$J,358.3,16135,1,3,0)
 ;;=3^CEFEPIME HCL INJ 500MG
 ;;^UTILITY(U,$J,358.3,16136,0)
 ;;=J2185^^104^998^33^^^^1
 ;;^UTILITY(U,$J,358.3,16136,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16136,1,2,0)
 ;;=2^J2185
 ;;^UTILITY(U,$J,358.3,16136,1,3,0)
 ;;=3^MEROPENEM 100MG
 ;;^UTILITY(U,$J,358.3,16137,0)
 ;;=J1200^^104^998^11^^^^1
 ;;^UTILITY(U,$J,358.3,16137,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16137,1,2,0)
 ;;=2^J1200
 ;;^UTILITY(U,$J,358.3,16137,1,3,0)
 ;;=3^DIPHENHYDRAMINE HCL INJ 50MG
 ;;^UTILITY(U,$J,358.3,16138,0)
 ;;=J2780^^104^998^48^^^^1
 ;;^UTILITY(U,$J,358.3,16138,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16138,1,2,0)
 ;;=2^J2780
 ;;^UTILITY(U,$J,358.3,16138,1,3,0)
 ;;=3^RANITIDINE HCL INJ 25MG
